Table 1 Expanded Programme on Immunization (EPI) schedules in Ghana
Num. | Vaccine | Age | Dose | Route/site of administration | Disease(s) |
|---|---|---|---|---|---|
1 | BCG | At birth | 0.05 ml | Intradermal right upper arm | Tetanus |
2 | OPV0 | At birth | 2drops | Oral | Poliomyelitis |
1 | DPT-HepB-Hib1 | 6 weeks | 0.5 ml | IM, lateral part of left thigh | Diphtheria, pertussis, Tetanus, Hepatitis B and Haemophilus Influenza type B |
2 | OPV1 | 6 weeks | 2drops | Oral | Poliomyelitis |
3 | Pneumo 1 | 6 weeks | 0.5 ml | IM, lateral part of right thigh | Pneumococcal diseases (pneumonia) |
4 | Rota 1 | 6 weeks | 1.5 ml vial | Oral | Diarrhoea |
1 | OPV2 | 10 weeks | 2drops | Oral | Poliomyelitis |
2 | DPT-HepB-Hib2 | 10 weeks | 0.5 ml | IM, lateral part of left thigh | Diphtheria, pertussis, Tetanus, Hepatitis B and Haemophilus Influenza type B |
3 | Pneumo 2 | 10 weeks | 0.5 ml | IM, lateral part of right thigh | Pneumococcal diseases (pneumonia) |
4 | Rota 2 | 10 weeks | 1.5 ml vial | Oral | Diarrhoea |
1 | OPV3 | 14 weeks | 2drops | Oral | Poliomyelitis |
2 | DPT-HepB-Hib3 | 14 weeks | 0.5 ml | IM, lateral part of left thigh | Diphtheria, pertussis, Tetanus, Hepatitis B and Haemophilus Influenza type B |
3 | Pneumo 3 | 14 weeks | 0.5 ml | IM, lateral part of right thigh | Pneumococcal diseases (pneumonia) |
4 | Rota 3 | 14 weeks | 1.5 ml vial | Oral | Diarrhoea |
1 | Vitamin A | 6 months | 100,000 IU | Oral | Diet supplementation |
2 | Measles-Rubella | 9 months | 0.5 ml | Subcutaneous, left upper arm | Measles, Rubella |
3 | Yellow fever | 9 months | 0.5 ml | Subcutaneous, right upper arm | Yellow fever |
1 | Vitamin A | 12 months | 200,000 IU | Oral | Diet supplementation |
1 | Measles | 18 months | 0.5 ml | Subcutaneous, left upper arm | Measles |
2 | Vitamin A | 18 months | 200,000 IU | Oral | Diet supplementation |